Germline truncating mutations in both MSH2 and BRCA2 in a single kindred

British Journal of Cancer

Volumn 90, Issue 2, 2004, Pages 483-491

  Thiffault, I ^a,b,c   Hamel, N ^a,c   Pal, T ^d   McVety, S ^a,b   Marcus, V A ^a   Farber, D ^a   Cowie, S ^e   Deschenes J ^a   Meschino, W ^d   Odefrey, F ^f   Goldgar, D ^f   Graham, T ^g   Narod, S ^d   Watters, A K ^a   MacNamara, E ^b   Du Sart, D ^e   Chong, G ^b   Foulkes, W D ^a,b,c,h  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^h MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Astrocytoma; BRCA2; Breast cancer; Colorectal cancer; Microsatellite instability; MSH2; Multiple primary cancers

Indexed keywords

BRCA2 PROTEIN; COMPLEMENTARY DNA; DNA; PROTEIN MSH2;

ADULT; ALU SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER INVASION; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA SEQUENCE; DNA STRAND BREAKAGE; ENDOMETRIUM CANCER; EXON; FEMALE; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; GERM LINE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LINKAGE ANALYSIS; MALE; MICROSATELLITE INSTABILITY; MUTATIONAL ANALYSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; RELATIVE;

ADULT; AGED; BASE SEQUENCE; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; FEMALE; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; LINKAGE (GENETICS); MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTS HOMOLOG 2 PROTEIN; NEOPLASMS, MULTIPLE PRIMARY; PEDIGREE; POLYMERASE CHAIN REACTION; PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 10744226607     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601424     Document Type: Article

References (29)

1. Aarnio M, Mecklin JP, Aaltonen LA, Nystromlahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430-433
2. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt W, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257
3. Borg A, Isola J, Chen J, Rubio C, Johansson U, Werelius B, Lindblom A (2000) Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer 85: 796-800
4. Caluseriu O, Cordisco EL, Viel A, Majore S, Nascimben R, Pucciarelli S, Genuardi M (2001) Four novel MSH2 and MLH1 frameshift mutations and occurrence of a breast cancer phenocopy in hereditary nonpolyposis colorectal cancer. Hum Mutat 17: 521
5. Chappuis PO, Hamel N, Paradis AJ, Deschenes J, Robidoux A, Potvin C, Cantin J, Tonin P, Ghadirian P, Foulkes WD (2001) Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. Clin Genet 59: 418-423
6. Chappuis PO, Nethercot V, Foulkes WD (2000) Clinico-pathological characteristics of BRCA1-and BRCA2-related breast cancer. Semin Surg Oncol 18: 287-295
7. Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, Puisieux A, Frebourg T (2002) MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 62(3): 848-853
8. Desai DC, Lockman JC, Chadwick RB, Gao X, Percesepe A, Evans DG, Miyaki M, Yuen ST, Radice P, Maher ER, Wright FA, de la Chapelle A (2000) Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 37: 646-652
9. Entius MM, Keller JJ, Drillenburg P, Kuypers KC, Giardello FM, Offerhaus GJ (2000) Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 6: 1784-1789
10. Hamilton SR, Lui B, Parsons RE, Papadopoulos N, Jen J, Powell SM, Krush Aj, Berk T, Cohen Z (2002) The molecular basis of Turcot syndrome. N Engl J Med 332: 839-847
11. Honchel R, Halling KC, Schaid DJ, Pittelkow M, Thibodeau SN (1994) Microsatellite instability in Muir-Torre syndrome. Cancer Res 54: 1159-1163
12. Kruse R, Lamberti C, Wang Y, Ruelfs C, Bruns A, Esche C, Lehmann P, Ruzicka T, Rutten A, Friedl W, Propping P (1996) Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet 98: 747-750
13. Leung SY, Chan TL, Chung LP, Chan AS, Fan YW, Hung KN, Kwong WK (1998) Microsatellite instability and mutation of DNA mismatch repair genes in gliomas. Am J Pathol 153: 1181-1188
14. Luce MC, Marra G, Chauhan DP, Laghi L, Carethers JM, Cherian SP, Hawn M, Binnie CG, Kam-Morgan LN, Cayouette MC (1995) In vitro transcription/ translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterol 109: 1368-1374
15. Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36: 801-818
16. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M (1999) Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 23: 1248-1255
17. Miyaki M, Nishio J, Konishi M, Kikuchi-Yanoshita R, Tanaka K, Muraoka M, Nagato M, Chong JM (1997) Drastic genetic instability of tumors and normal tissues in Turcot syndrome. Oncogene 15: 2877-2881
18. Muller A, Edmonston TB, Corao DA, Rose DG, Pallazo JP, Becker H, Fry RD, Rueschoff J, Fishel R (2002) Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res 62: 1014-1019
19. Newschaffer CJ, Topham A, Herzberg T, Weiner S, Weinberg DS (2001) Risk of colorectal cancer after breast cancer. Lancet 357: 837-840
20. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, Jarvinen HJ, Mecklin JP, Kinzler KW, Vogelstein B et al (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1(11): 1203-1206
21. Peltomaki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10: 735-740
22. Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JLA, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68: 700-710
23. Risinger JI, Barrett JC, Watson P, Lynch HT, Boyd J (1996) Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer 77: 1836-1843
24. Thompson DJ, Douglas F, Easton DF, Breast Cancer Linkage Consortium (2002) Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94: 1358-1365
25. Vasen HF, Sanders EA, Taal BG, Nagengast FM, Griffioen G, Menko FH, Kleibeuker JH, Houwing-Duistermaat JJ, Meera Khan P (1996) The risk of brain tumours in hereditary non-polyposis colorectal cancer (HNPCC). Int J Cancer 65: 422-425
26. Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453-1456
27. Viel A, Petronzelli F, Della Puppa L, Lucci-Cordisco E, Fornasarig M, Pucciarelli S, Rovella V, Quaia M, Ponz de Leon M, Boiocchi M, Genuardi M (2002) Different molecular mechanisms underlie genomic deletions in the MLH1 Gene. Hum Mutat 20(5): 368-374
28. Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E (2003) Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 103(5): 636-641
29. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Meijers Heijboer H, Lindhout D, Moller P, Fodde R (1998) MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 20(4): 326-328